Earnings call Advanced Enzymes reported 5% YoY revenue growth in Q1 FY25, with EBITDA up 16% and PAT up 19%, driven by margin expansion to 33%. Management reaffirmed full-year revenue growth guidance ...

Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! We often see insiders buying up shares in companies that perform well over the long term.

Shares of Advanced Enzyme Technologies Ltd slumped in Monday's trade after the small-cap biotechnology firm posted weak second-quarter results. The stock tanked 11.85 per cent to hit a day low of Rs ...

Rasika Rathi is a highly accomplished lawyer and board member of Specialty Enzymes & Probiotics, a group company of Advanced Enzyme Technologies. In her current role as general counsel of Advanced ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

United Statescategory Exclusive: Flights halted for Afghans approved for special US visas, advocate and official say 1:31 AM UTC United Statescategory Trump says he may consider rejoining World Health ...

Earnings call Advanced Enzymes' Q2 FY25 revenue declined 7% YoY to ₹1,461M due to export slowdown and ₹83M in deferred revenue. EBITDA margin dropped to 29%. Despite H1 softness, management expects ...